GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (NSE:IPCALAB) » Definitions » Operating Cash Flow per Share

Ipca Laboratories (NSE:IPCALAB) Operating Cash Flow per Share : ₹0.00 (TTM As of Dec. 2023)


View and export this data going back to 1995. Start your Free Trial

What is Ipca Laboratories Operating Cash Flow per Share?

Ipca Laboratories's operating cash flow per share for the three months ended in Dec. 2023 was ₹0.00. Ipca Laboratories's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 12.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 20.50% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Ipca Laboratories's Operating Cash Flow per Share or its related term are showing as below:

NSE:IPCALAB' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -18.6   Med: 20.75   Max: 47.1
Current: 12.1

During the past 13 years, Ipca Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.10% per year. The lowest was -18.60% per year. And the median was 20.75% per year.

NSE:IPCALAB's 3-Year OCF Growth Rate is ranked better than
55.33% of 806 companies
in the Drug Manufacturers industry
Industry Median: 8.1 vs NSE:IPCALAB: 12.10

Ipca Laboratories Operating Cash Flow per Share Historical Data

The historical data trend for Ipca Laboratories's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Operating Cash Flow per Share Chart

Ipca Laboratories Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 19.83 22.55 43.04 33.74 31.76

Ipca Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ipca Laboratories's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ipca Laboratories's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Ipca Laboratories's Price-to-Operating-Cash-Flow falls into.



Ipca Laboratories Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Ipca Laboratories's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (A: Mar. 2023 )=Cash Flow from Operations (A: Mar. 2023 )/Shares Outstanding (Diluted Average) (A: Mar. 2023 )
=8058.1/253.704
=31.76

Ipca Laboratories's Operating Cash Flow per Share for the quarter that ended in Mar. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )=Cash Flow from Operations (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=0/253.709
=0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ipca Laboratories Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ipca Laboratories (NSE:IPCALAB) Business Description

Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (NSE:IPCALAB) Headlines

No Headlines